ライフサイエンスコーパス: dermatologist

1 masked fashion by a dermatopathologist and a dermatologist.

2 kin lesion determined by an examination of a dermatologist.

3 atients diagnosed or surgically treated by a dermatologist.

4 s and severity of AD assessed by a pediatric dermatologist.

5 ween the teledermatologist and the in-person dermatologist.

6 ble to obtain an appointment with any listed dermatologist.

7 l condition that had not been evaluated by a dermatologist.

8 e distinct perspectives of the allergist and dermatologist.

9 ults with manually determined borders from a dermatologist.

10 th reinforcement every 4 months by the study dermatologist.

11 imination of unnecessary appointments with a dermatologist.

12 ondition as established by a board-certified dermatologist.

13 014, 8614 (2.2%) had 1 or more visits with a dermatologist.

14 as morphologically suspicious nevi by the 9 dermatologists.

15 xamination and pursue regular follow-up with dermatologists.

16 hen performed by experienced board-certified dermatologists.

17 on cosmetic dermatology, with a total of 23 dermatologists.

18 and physical examination by board-certified dermatologists.

19 cal plausibility that is likely to appeal to dermatologists.

20 inspection of the lesion skin by experienced dermatologists.

21 outinely by both primary care physicians and dermatologists.

22 ess sensitive than examinations performed by dermatologists.

23 cer with a level of competence comparable to dermatologists.

24 quently request product recommendations from dermatologists.

25 the characteristics of industry payments to dermatologists.

26 he nature and extent of industry payments to dermatologists.

27 ith aBCC, 16 with BCCNS) and 4 physicians (2 dermatologists, 1 Mohs surgeon, and 1 oncologist) in the

28 referred patients were seen and treated by a dermatologist; 127 patients (50.2%) were not on prescrip

29 re all pharmaceutical manufacturers and paid dermatologists $28.7 million, representing 81% of total

30 Forty-five dermatologists (29 male and 16 female) performed the eva

31 Four dermatologists, 3 pulmonologists, and 4 rheumatologists

32 were significantly more often discharged by dermatologists (46.8% vs 39.1%) (P < 10(-4)).

33 Of all patients who visited a dermatologist, 48.5% received care via teledermatology.

34 Nine dermatologists (6 of whom had >/=3 years of RCM experien

35 The use of PDL offers dermatologists a new treatment modality for PPPs that is

36 e itch for several months, asked whether the dermatologist accepted the relevant plan, and asked for

37 tients had 1085985 claims related to AK, and dermatologists accounted for 71.0% of claims.

38 2 of 189 patients (32.8%) were referred to a dermatologist after 33 (53.2%) for presumptive skin canc

39 d signs of actinic skin damage identified by dermatologists), age, and sex compared with wild-type ca

40 lines, swirls, and whorls first noted by the dermatologist Alfred Blaschko.

41 in 2 private consultant rooms of specialist dermatologists, all located in Sydney and Gosford, New S

42 s (AD) is a common skin condition treated by dermatologists, allergists, pediatricians, and primary c

43 re evaluated separately by both an in-person dermatologist and 2 independent teledermatologists.

44 ember 26, 2014, in the private practice of a dermatologist and a gynecologist in Sydney, Australia.

45 ect was carefully examined by an experienced dermatologist and stringent diagnostic criteria applied.

46 ial triage concordance between the in-person dermatologist and teledermatologists were 0.41 and 0.48.

47 re obtained in the office-based setting by a dermatologist and with an iPhone by the patient at basel

48 Four observers (3 dermatologists and 1 dermatopathologist) blinded to the

49 isparity in the perceptions of AD between US dermatologists and allergists and health care profession

50 The efforts of dermatologists and cancer biologists to understand how U

51 dvocacy organizations in the CSD among Texas dermatologists and dermatology residents and patient reg

52 ng member organizations of the CSD and among dermatologists and dermatology residents in Texas from A

53 nts a transformative technology that impacts dermatologists and dermatopathologists from residency to

54 tis is a common disorder that has fascinated dermatologists and immunologists for decades.

55 y to expand the use of the CSAMI and SASI by dermatologists and nondermatologists in assessing cutane

56 s sarcoidosis outcome instruments for use by dermatologists and nondermatologists treating sarcoidosi

57 Regular communication between dermatologists and oncologists will help facilitate the

58 Opportunities exist for dermatologists and other physicians to influence occupat

59 cases of SCC were identified by a network of dermatologists and pathology laboratories.

60 The final instrument was evaluated by five dermatologists and six residents who scored nine patient

61 rm the reliability of the CLASI when used by dermatologists and support the CLASI as a reliable instr

62 ic images were evaluated by the office-based dermatologist, and mobile dermoscopic images were sent v

63 tilized scoring of 60 test photographs by 10 dermatologists, and one with in-person evaluations on 85

64 ment by ophthalmologists, otolaryngologists, dermatologists, and oral medicine specialists.

65 s seen by general pediatricians, allergists, dermatologists, and other specialists.

66 soriasis, including primary care clinicians, dermatologists, and pediatric specialists.

67 racy of MA plan directories of participating dermatologists,and the appointment availability of liste

68 reflectance spectrophotometry compared with dermatologist- and participant-determined FST.

69 n performed by a primary care clinician vs a dermatologist; and whether its use leads to earlier dete

70 rveillance and early referral to a dedicated dermatologist are recommended.

71 pic images whose manually drawn borders by a dermatologist are used as the ground truth.

72 drugs available in the armamentarium of the dermatologists are either substrate, inducer, or inhibit

73 Dermatologists are frequently asked to see patients with

74 Investigative dermatologists are needed to drive and orient this cross

75 Even though dermatologists are trained to recognize patterns of morp

76 linician (RR, 0.81; 95% CI, 0.71-0.93) was a dermatologist as compared with a nondermatologist.

77 exposure and investigated the association of dermatologist-assessed hair loss with prostate cancer-sp

78 ns clinically diagnosed by a board-certified dermatologist at a large tertiary referral center, where

79 ns clinically diagnosed by a board-certified dermatologist at a large tertiary referral center, where

80 Participants were evaluated by dermatologists at 3-month intervals for 18 months.

81 s on the face and ears were counted by study dermatologists at enrollment and at study visits every 6

82 h in-person evaluations on 85 subjects by 12 dermatologists at the Foundation for Ichthyosis and Rela

83 commend specific software tools that can aid dermatologists at varying levels of computational litera

84 n diagnoses made by an independent pediatric dermatologist based on in-person examination and those b

85 Dermatologists based in outpatient settings can find it

86 macovigilance cohort (British Association of Dermatologists Biologic Interventions Register (BADBIR))

87 ients enrolled in the British Association of Dermatologists Biologic Interventions Register were incl

88 l using data from the British Association of Dermatologists Biologic Interventions Register.

89 , 2010, and October 21, 2010, participanting dermatologists, blinded to histopathological diagnosis,

90 Dermatologists can discuss hair management strategies du

91 Dermatologists can identify patients with a high likelih

92 Study dermatologists conducted physical examinations at baseli

93 eas the proportion of this care delivered by dermatologists decreased from 39.6% to 37.9%.

94 osa are becoming more widely recognized, but dermatologists, dermatopathologists, and histopathologis

95 Faculty dermatologists determined a rosacea score for each twin

96 Dermatologist-determined FST is more accurate than self-

97 Participant responses to tanning and the dermatologist-determined FST were not significantly corr

98 Participant responses to burning and the dermatologist-determined FST were significantly correlat

99 The spectrophotometry measurements for dermatologist-determined FST were significantly differen

100 accuracy of self-report of FST compared with dermatologist-determined FST.

101 Dermatologists diagnose and treat sexually transmitted i

102 ses were limited to patients with a hospital dermatologist diagnosis of rosacea only, the adjusted HR

103 y for skin cancer or precancer compared with dermatologist diagnosis were assessed in screened patien

104 with vitiligo and/or AA were identified from dermatologist documentation and photographic evidence.

105 ader-multiple-case study, 45 board-certified dermatologists each evaluated 60 clinical and dermoscopi

106 The patient's dermatologist elected to change antibiotics.

107 Ten dermatologists evaluated 14 patients with DM using the C

108 ory asynchronously to dermatologists online; dermatologists evaluated the clinical information, provi

109 diagnosed as having cellulitis by PCPs, but dermatologist evaluation determined that 6 (67%) of thes

110 Two academic dermatologists examined clinical notes, pathology report

111 The scores from 12 dermatologists experienced in PASI evaluation were used

112 Three dermatologists familiar with immunobullous diseases and

113 oup comprised of 10,714 patients who visited dermatologists, family physicians, or allergy specialist

114 patients who received a prescription from a dermatologist for a primary initial diagnosis of acne vu

115 Each section is examined by a dermatologist for abrupt cutoff and scored accordingly,

116 ends the image directly to a board-certified dermatologist for analysis; the lowest, for applications

117 Of 376 patients, two were referred to a dermatologist for evaluation, but neither had signs indi

118 n of all races, >/=18 years) presenting to 1 dermatologist for melanoma and/or skin cancer screening

119 n patients with indemnity insurance to see a dermatologist for skin problems, and it was predicted th

120 53 referrals from primary care clinicians to dermatologists for acne from January 2014 through March

121 omen), were randomly presented to the same 9 dermatologists for blinded assessment from September 22,

122 dance was moderate between ED physicians and dermatologists for specialist consultation within 24 hou

123 Dermatologists frequently encounter patients of advanced

124 All payments to dermatologists from companies making products reimbursed

125 creening [LDS]) were screened by a team of 6 dermatologists from March 14 to 18, 2014, for TSBE and A

126 creening [LDS]) were screened by a team of 6 dermatologists from March 14 to 18, 2014, for TSBE and A

127 st, the offices of nationally representative dermatologists from the National Disease and Therapeutic

128 Surveys of dermatologists, gastroenterologists, and ophthalmologist

129 In our secondary analysis, 2 independent dermatologists graded these photographs using 4 validate

130 anomas that underwent biopsy and excision by dermatologists had the lowest likelihood of delay (proba

131 adership required that young German-speaking dermatologists had to seek additional training in the Un

132 ach participant was clinically examined by 2 dermatologists, had laboratory studies performed, was ad

133 provision of samples with a prescription by dermatologists has been increasing over time, and this i

134 ity of this test in biopsy decisions made by dermatologists has not been evaluated.

135 e; low awareness and patient referrals among dermatologists have presented an obstacle to this.

136 ave largely been agreed upon, allergists and dermatologists have similar and divergent approaches to

137 se patients undergoing biopsy and surgery by dermatologists have the lowest risk for delay, highlight

138 y a pigmented lesion suggestive of melanoma, dermatologists improved their mean biopsy sensitivity fr

139 dy using questionnaires and evaluations by a dermatologist in adults with atopic dermatitis (n = 261)

140 Although the leading roles of dermatologists in diagnosing recent outbreaks of cutaneo

141 These results might help dermatologists in guiding therapeutic decisions, especia

142 d tumors, highlighting an important role for dermatologists in identifying and screening patients wit

143 ents preferred professional attire for their dermatologists in most settings.

144 t with past satisfaction studies and may aid dermatologists in optimizing the patient care experience

145 omponents of diagnostic procedures to assist dermatologists in their medical decision-making processe

146 In the in-person group, patients visited dermatologists in their offices for follow-up care.

147 consumer sunscreen preferences would inform dermatologists in their own recommendations.

148 ntage of patients with at least 1 visit to a dermatologist (including in-person and teledermatology v

149 eledermatology visits) and total visits with dermatologists (including in-person and teledermatology

150 considered, however, the number of visits to dermatologists increased from the 1989 level, reaching a

151 Three dermatologists independently rated all 3 indexes for eac

152 Access to specialists such as dermatologists is often limited for Medicaid enrollees.

153 ion, and SF-36 scores did not correlate with dermatologists' judgments about the severity of skin dis

154 dermatologist preparedness for bioterrorism, dermatologist knowledge regarding smallpox vaccination h

155 When performed by dermatologists, LDS is an acceptable alternative screeni

156 cripted telephone calls were placed to every dermatologist listed in directories for the largest MA p

157 Many of the dermatologists listed had incorrect contact information,

158 Optimizing referrals to a dermatologist may reduce patient wait times.

159 We illustrate the bias that dermatologists may have in exclusively associating patie

160 In 201 patients seen by dermatologists, mean scale scores (+/-SD) ranged from 14

161 udy using questionnaires and evaluation by a dermatologist (n = 265).

162 a primary diagnosis of rosacea by a hospital dermatologist (n = 5964), the adjusted incidence rate ra

163 atosis (SK), and benign nevi by a consultant dermatologist (n=87) were imaged by high-resolution ultr

164 were rated with the CLASI by academic-based dermatologists (n = 5) and rheumatologists (n = 5).

165 .6% when skin examinations were performed by dermatologists (n = 7436).

166 The top 10% of dermatologists (n = 833) received more than $31.2 millio

167 Care by a dermatologist (odds ratio [OR], 6.7; 95% CI, 5.2-8.6) pr

168 spective study in a clinical practice of one dermatologist of biopsy data of all skin lesions from on

169 t its performance against 21 board-certified dermatologists on biopsy-proven clinical images with two

170 To assess the agreement of dermatologists on identification of the ugly duckling si

171 rototypes of the dominance of German-trained dermatologists on the specialty in the US that persisted

172 Dermatologists, oncologists, and nephrologists need to b

173 linical images and history asynchronously to dermatologists online; dermatologists evaluated the clin

174 xture, with regular long-term follow-up by a dermatologist or gynecologist.

175 ess frequently in direct consultation with a dermatologist or regular screening for skin cancer.

176 rolled in this program were either certified dermatologists or senior dermatology residents.

177 devices can potentially extend the reach of dermatologists outside of the clinic.

178 encountered in pure forms by allergists and dermatologists, patients with AD often present with incr

179 ical procedures including those performed by dermatologists, plastic surgeons, and general surgeons.

180 and monkeypox demonstrate the importance of dermatologist preparedness for bioterrorism, dermatologi

181 National trends in dermatologist prescribing patterns, the degree of correl

182 bility of free prescription drug samples and dermatologists' prescribing patterns on a national scale

183 Importance: Dermatologists, pulmonologists, and rheumatologists stud

184 Two blinded dermatologists rated the sites at 12 weeks after the ini

185 75.7% (1474 of 1947) of those who visited a dermatologist received care via teledermatology.

186 Results: A total of 8333 dermatologists received 208613 payments totaling more th

187 Conclusions and Relevance: Dermatologists received substantial payments from the ph

188 If the in-person dermatologist recommended a biopsy, the teledermatologis

189 decisions were as follows: if the in-person dermatologist recommended the patient be seen the same d

190 Products with the claim "dermatologist recommended" had higher median price per o

191 ounce on the basis of marketing claims (eg, dermatologist recommended, fragrance free, hypoallergeni

192 Dermatologists recorded the mention of sunscreen the mos

193 tive effort by groups of rheumatologists and dermatologists regarding development of screening questi

194 The agreement among the dermatologists regarding UDN was lower with dermoscopic

195 Access to dermatologists remains a nationwide challenge.

196 However, dermatologists reported mentioning sunscreen at only 1.6

197 With most dermatologists residing in metropolitan areas, telederma

198 The pediatric dermatologist's arsenal of topical anesthetic preparatio

199 In the absence of a dermatologist's examination, no reliable tool exists to

200 A group of 10 dermatologists scored 15 patients with pemphigus to esti

201 Two blinded dermatologists separately rated participants' acne scars

202 he years 1990-1992 to examine utilization of dermatologist services over a period in which managed ca

203 would result in a slowing in the demand for dermatologist services.

204 ble comparison data on moisturizer efficacy, dermatologists should balance consumer preference, price

205 Dermatologists should balance the importance of cosmetic

206 Dermatologists should be aware of this low-grade cutaneo

207 Dermatologists should be familiar with the severe varian

208 Widespread dermatologist smallpox vaccination knowledge deficits pi

209 nizing that a cure lies in timely detection, dermatologists strive to diagnose malignant melanoma (MM

210 linical response as assessed by the treating dermatologist, subjective quality of life as reported by

211 Dermatologists, surgeons, and oncologists must rely on t

212 s likely to have their skin care provided by dermatologists than patients with commercial insurance (

213 ation; percentage of patients evaluated by a dermatologist through either teledermatology or in-perso

214 nts (120 of 144 [83.3%]) were evaluated by a dermatologist through either teledermatology or in-perso

215 s over time, representing an opportunity for dermatologists to evaluate performance and validate prac

216 tforms provide elaborate and timely data for dermatologists to garner insight into their patients' ex

217 The ability of dermatologists to identify and direct patients with this

218 This stresses the necessity for dermatologists to perform comprehensive medical historie

219 It is important for practicing dermatologists to recognize patients who may be less lik

220 The noninvasive PLA enables dermatologists to significantly improve biopsy specifici

221 patic manifestation of NASH should sensitize dermatologists to the screening and the management of fa

222 atology may provide a valuable mechanism for dermatologists to triage inpatient consultations and inc

223 It is important for dermatologists to understand and recognize CRPS as a neu

224 hat grew out of efforts by immunologists and dermatologists to understand immune regulation by UV rad

225 tion and should be of continuous concern for dermatologists, transplant physicians, and patients.

226 Dermatologists treat actinic keratoses to prevent non-me

227 In addition, the patient's dermatologist treated his palmoplantar keratoderma with

228 cordance between primary care clinicians and dermatologists, treatment at the time of referral, and t

229 rease in the fraction of patients visiting a dermatologist (vs 20.5% in other practices; P < .01).

230 The median total payment per dermatologist was $298 with an interquartile range of $9

231 A reduction in the number of visits to dermatologists was observed among patients with HMO/prep

232 12, on the basis of an initial report from a dermatologist, we began to investigate an outbreak of ta

233 environment has resulted in fewer visits to dermatologists, we used National Ambulatory Medical Care

234 at the time of referral, and treatment by a dermatologist were ascertained, and we modeled 2 treatme

235 ns of the teledermatologist and office-based dermatologist were compared.

236 uries, American physicians wishing to become dermatologists were highly dependent on training in Euro

237 5 of 7287 visits [46.7%]), whereas in-person dermatologists were more likely to care for psoriasis an

238 ed cross-sectional screenings by a team of 6 dermatologists were organized in 2 sociodemographically

239 n by a gynecologist; patients were seen by a dermatologist when there were cutaneous and/or mucous le

240 went a complete skin examination by the same dermatologist who examined them initially.

241 ration and futility in both patients and the dermatologists who care for them.

242 public and other medical specialties expect dermatologists who offer cosmetic dermatology services t

243 ed from the influx of several stellar Jewish dermatologists who were major contributors to the subseq

244 independently evaluated by 2 board-certified dermatologists, who provided diagnoses and treatment pla

245 ges of all nevi of each patient shown to the dermatologists, who were asked to identify ugly duckling

246 as well as neurologist, ophthalmologist, and dermatologist, will provide a global spectrum of care fo